Sign In

Expanding the Boundaries for Liver Transplant Oncology

Date/Time

  • Friday, November 9, 8:00 am – 3:00 pm

Program Chairs

  • Roberto Hernandez-Alejandro, MD
  • Mitra K. Nadim, MD
  • Marina Berenguer, MD

Session Description / Needs Statement

Approximately 24,000 liver transplants are performed annually worldwide. Survival is excellent and continues to improve, with one-year survival currently exceeding 85%. Unfortunately, there remains a gap between the need for liver transplantation and the number of available donor organs. To close this gap, there is a need to innovative procurement and optimization of donor organs. This course will look at the impact of anti-HCV therapies, donation after cardiac death and perfusion strategies in donor organ availability. The course will also review the knowledge of liver transplant oncology (including out-of-Milan hepatocellular carcinoma) cholangiocarcinoma and colon cancer metastasis. Finally, the course will discuss ways attendees can ensure ongoing innovation and expanding the utility of transplantation.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Understand the impact of anti-HCV therapies, donation after cardiac death and perfusion strategies in donor organ availability
  • Update the knowledge of liver transplant oncology, including out-of-Milan hepatocellular carcinoma, cholangiocarcinoma and colon cancer metastasis
  • Promote self and program analysis to ensure ongoing innovation and expanding the utility of transplantation

Continuing Education Information

  • CME – 5.75 AMA PRA Category 1 Credits™
  • CE – 5.5 Hours
  • * (eligible for 4.25 pharmacology hours)

To view full programming being offered at The Liver Meeting®, visit the 2018 Online Program.

Session I: Increasing Donor Organ Availability

Moderator: Marina Berenguer, MD

  • 8:00 am - 8:10 am
    Welcome and Introductions
  • 8:10 am - 8:30 am
    The End of the HCV Epidemic: An Opportunity for Spare Organs
    Norah Terrault, MD, MPH, FAASLD
  • 8:30 am - 8:50 am
    DCD: The Solution to Expand Organ Availability (YES?)
    Miriam Cortes Cerisuelo, MD, PhD
    DCD: The Solution to Expand Organ Availability (NO?)
    Nazia Selzner, MD, PhD
  • 8:50 am - 9:10 am
    Perfusion Strategies and Organ Repair: Where’s the Limit?
    Markus Selzner, MD
  • 9:10 am - 9:30 am
    Matching Donors and Recipients to Achieve the Best Outcomes
    Simone I. Strasser, MD
  • 9:30 am - 9:50 am
    Panel Discussion
  • 9:50 am - 10:10 am
    Break

Session II: State-of-the-Art in Transplant Oncology: What’s Working, What’s Not?

Moderator: Elizabeth Pomfret, MD, PhD

  • 10:10 am - 10:25 am
    HCC for Outside Milan Criteria: Current Evidence
    Susan L. Orloff, MD, FACS, FAASLD
  • 10:25 am - 10:40 am
    Downstaging Strategies: Pre-LT Approaches
    Laura M. Kulik, MD
  • 10:40 am - 10:55 am
    LT vs Resection for the Very Small HCC
    Neil Mehta, MD
  • 10:55 am - 11:10 am
    Hilar Cholangiocarcinoma
    Julie Heimbach, MD, FAASLD
  • 11:10 am - 11:25 am
    Neuroendocrine Tumors vs Liver Resection vs Non-surgical Options
    Vincenzo Mazzaferro, MD
  • 11:25 am - 11:40 am
    Pediatrics Transplant Oncology
    Yuri Genyk, MD
  • 11:40 am - Noon
    Panel Discussion
  • Noon - 1:00 pm
    Intermission

Session III: Pushing the Envelope: Innovation in Medical Oncology

Moderator: Roberto Hernandez-Alejandro, MD

  • 1:00 pm - 1:15 pm
    Colorectal Liver Metastases
    Svein Dueland, MD, PhD
  • 1:15 pm - 1:30 pm
    Intrahepatic Cholangiocarcinoma or HCC-CC
    Gonzalo Sapisochin, MD
  • 1:30 pm - 1:50 pm
    LDLT vs Deceased Donors (Deceased Donors)
    Bijan Eghtesad, MD
    LDLT vs Deceased Donors (Live Donors)
    Elizabeth Pomfret, MD, PhD
  • 1:50 pm - 2:10 pm
    Immunosuppression and Chemotherapy in Transplant Oncology (Immunosuppression)
    Kimberly D. Watt, MD
    Immunosuppression and Chemotherapy in Transplant Oncology (Chemotherapy)
    Richard Finn, MD
  • 2:10 pm - 2:30 pm
    The Contribution of Radiology and Pathology in Transplant Oncology (Radiology)
    Kathryn Fowler, MD
    The Contribution of Radiology and Pathology in Transplant Oncology (Pathology)
    Valérie Paradis, MD, PhD
  • 2:30 pm - 2:50 pm
    Panel Discussion
  • 2:50 pm - 3:00 pm
    Closing Remarks